Continuous Positive Airway Pressure (CPAP) Masks Market Size, Share and Global Trend By Type of Masks (Nasal Masks, Full Face Masks, Nasal Pillows, Pediatric masks), By Patient Type (Pediatric, Adults), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) and Geography Forecast till 2021-2028

Continuous Positive Airway Pressure (CPAP) therapy is a clinical treatment for moderate or severe obstructive sleep apnea. The forced air delivered by Continuous Positive Airway Pressure (CPAP) devices prevent episode of airway collapse that blocks the breathing in patients with obstructive sleep apnea and other related problems. Continuous positive airway pressure (CPAP) therapy is one of the most common treatment for people suffering from sleep apnea.

Continuous positive airway pressure (CPAP) therapy is also used in infants and pediatric patients suffering from breathing disorders. Continuous Positive Airway Pressure (CPAP) systems include a machine, flexible tube and a mask.The tube connects the machine to the mask. Continuous Positive Airway Pressure (CPAP) masks are designed to cover only the nose or both the nose and the mouth. Different types of masks are available in market, including nasal masks, full face mask, pediatric masks and nasal pillow masks.

To gain extensive insights into the market,Request for Customization

In 2016, according to the World Health Organization (WHO), globally an estimated 1.9 billion adults above the age of 18 years were overweight, out of which 650 million were obese. Also, according to data published at the ATS 2018 International Conference, an estimated 1 billion people globally suffer from sleep apnea. This increase in number of patients suffering from sleep apnea, combined with rise in obese population, is projected to fuel the demand for sleep apnea treatment devices including CPAP masks.

These factors are anticipated to drive the growth of the global CPAP masks market during 2019-2026. In 2018, Koninklijke Philips N.V. announced the launch of Dreamwear full mask with a goal of providing better option for sleep apnea patients. In 2017, ResMed announced the U.S. FDA approval for its Airmini, the world’s smallest CPAP device.

These technological advances in the Continuous Positive Airway Pressure (CPAP) devices and masks by market players, is anticipated to fuel the adoption of CPAP masks, and subsequently drive the growth of the global Continuous Positive Airway Pressure (CPAP) masks market during the forecast period.

However, lack of patients suffering from sleep apnea undergoing treatment, especially in emerging countries, combined with lower adherence to treatment, are some of the major factors restraining the growth of the global CPAP masks market.

Key Players Covered

Some of the major companies that are present in the global market of CPAP masks are AG industries, Koninklijke Philips N.V., ResMed, Fischer Paykel healthcare Ltd, Medline industries, Inc., KOIKE MEDICAL CO., LTD, DeVilbiss Healthcare LLC, Sunset Healthcare Solutions Inc., Sarnova, Inc., Teleflex Incorporated and other players.

SEGMENTATION

SEGMENTATION	DETAILS
By Type of Masks	· Nasal Masks · Full Face Masks · Nasal Pillows · Pediatric masks
By Patient Type	· Pediatric · Adults
By Distribution Channel	· Hospital Pharmacy · Online Pharmacy · Retail Pharmacy
By Geography	· North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico, Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key Insights

• Reimbursement Scenario for Key Countries


• Key Mergers and Acquisitions


• New Product Launches, Key Players/ Region


• Prevalence of Obstructive Sleep Apnea, Key Countries/ Region, 2018

Regional Analysis

Geographically, the global continuous positive airway pressure (CPAP) masks market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. CPAP masks market is currently dominated by North America. In North America, U.S. is the largest contributor, due to higher prevalence of sleep apnea, along with comparatively higher proportion of the patient population undergoing treatment in the U.S. Asia Pacific is projected to register comparatively higher growth in the global CPAP masks market due to the increase in diagnosis of sleep apnea in countries such as India and China.

Key Industry Developments

• In Sept 2018, ResMed announced a new full face mask CPAP masks ‘AirFit F30’ which prevents factor that causes claustrophobia in some patients.


• In 2018, Metamason a Southern California start-up company created a custom made CPAP masks designed for specific face & comfort requirement.


• In 2019, HSD ventures is developing LOA a lightwear & innovative full face CPAP mask which aims to provide simplicity, comfort & optimized airflow to patients with sleep apnea.


• In April 2019, ResMed launched AirFit P30i Nasal Pillow Masks in U.S.